Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-29 @ 9:48 AM
Study NCT ID:
NCT01080066
Status:
COMPLETED
Last Update Posted:
2014-07-08
First Post:
2010-02-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)
Sponsor:
Merck KGaA, Darmstadt, Germany